Cargando…

SMARCA4 mutations in KRAS‐mutant lung adenocarcinoma: a multi‐cohort analysis

KRAS is a key oncogenic driver in lung adenocarcinoma (LUAD). Chromatin‐remodeling gene SMARCA4 is comutated with KRAS in LUAD; however, the impact of SMARCA4 mutations on clinical outcome has not been adequately established. This study sought to shed light on the clinical significance of SMARCA4 mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Liang, Ahmed, Tamjeed, Petty, William J., Grant, Stefan, Ruiz, Jimmy, Lycan, Thomas W., Topaloglu, Umit, Chou, Ping‐Chieh, Miller, Lance D., Hawkins, Gregory A., Alexander‐Miller, Martha A., O’Neill, Stacey S., Powell, Bayard L., D’Agostino, Ralph B., Munden, Reginald F., Pasche, Boris, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858279/ https://www.ncbi.nlm.nih.gov/pubmed/33107184 http://dx.doi.org/10.1002/1878-0261.12831

Ejemplares similares

Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1
por: Liu, Liang, et al.
Publicado: (2018)

Prognostic Mutational Signatures of NSCLC Patients treated with chemotherapy, immunotherapy and chemoimmunotherapy
por: Smith, Margaret R., et al.
Publicado: (2023)

A tale of three subspecialties: Diagnosis recording patterns are internally consistent but Specialty-Dependent
por: Diaz-Garelli, Jose-Franck, et al.
Publicado: (2019)

Dissecting intratumoral myeloid cell plasticity by single cell RNA‐seq
por: Song, Qianqian, et al.
Publicado: (2019)

CD138 plasma cells may predict brain metastasis recurrence following resection and stereotactic radiosurgery
por: Soike, Michael H., et al.
Publicado: (2019)

A phase 1 study of first-in-class agent CPI-613 in combination with FOLFIRINOX for metastatic pancreatic cancer
por: Alistar, Angela, et al.
Publicado: (2017)

Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial
por: Dohm, Ammoren, et al.
Publicado: (2019)

Ciliogenesis and Hedgehog signalling are suppressed downstream of KRAS during acinar-ductal metaplasia in mouse
por: Bangs, Fiona K., et al.
Publicado: (2020)

Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023)

Complex Alternative Splicing of the Smarca2 Gene Suggests the Importance of Smarca2-B Variants
por: Yang, Min, et al.
Publicado: (2011)

Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
por: Cantley, Jennifer, et al.
Publicado: (2022)

Amplitude-modulated electromagnetic fields for the treatment of cancer: Discovery of tumor-specific frequencies and assessment of a novel therapeutic approach
por: Barbault, Alexandre, et al.
Publicado: (2009)

c-Met Mediated Cytokine Network Promotes Brain Metastasis of Breast Cancer by Remodeling Neutrophil Activities
por: Liu, Yin, et al.
Publicado: (2023)

High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
por: Guerrero-Martínez, Jose A., et al.
Publicado: (2018)

A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma
por: Lycan, Thomas W., et al.
Publicado: (2016)

Natural language processing and recurrent network models for identifying genomic mutation-associated cancer treatment change from patient progress notes
por: Guan, Meijian, et al.
Publicado: (2019)

Mutational Landscapes of Smoking-Related Cancers in Caucasians and African Americans: Precision Oncology Perspectives at Wake Forest Baptist Comprehensive Cancer Center
por: Kytola, Ville, et al.
Publicado: (2017)

Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type
por: Jelinic, Petar, et al.
Publicado: (2016)

Prevalence of DNA Repair Gene Mutations in Blood and Tumor Tissue and Impact on Prognosis and Treatment in HNSCC
por: Burcher, Kimberly M., et al.
Publicado: (2021)

Coordinated epigenetic regulation of Engrailed-1 by the chromatin remodelers Smarca1 and Smarca5 mediates cerebellar morphogenesis
por: Alvarez-Saavedra, Matias, et al.
Publicado: (2013)

Circulating mutational portrait of cancer: manifestation of aggressive clonal events in both early and late stages
por: Yang, Meng, et al.
Publicado: (2017)

Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma
por: Burcher, Kimberly M., et al.
Publicado: (2021)

The Prognostic and Therapeutic Value of the Mutational Profile of Blood and Tumor Tissue in Head and Neck Squamous Cell Carcinoma
por: Wilson, Harper L., et al.
Publicado: (2020)

Imaging in staging of malignant pleural mesothelioma
por: Truong, Mylene T, et al.
Publicado: (2004)

SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines
por: Ehrenhöfer-Wölfer, Katharina, et al.
Publicado: (2019)

The Emerging Roles of circSMARCA5 in Cancer
por: Qin, Haoyu, et al.
Publicado: (2022)

Thoracic SMARCA4-deficient undifferentiated tumor
por: Jiang, Jiapeng, et al.
Publicado: (2023)

Use of comprehensive genomic profiling for biomarker discovery for the management of non-small cell lung cancer brain metastases
por: Abdulhaleem, Mohammed, et al.
Publicado: (2023)

Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle Aspirates
por: Su, Jing, et al.
Publicado: (2021)

A potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS
por: Bery, Nicolas, et al.
Publicado: (2020)

Cure of Oligometastatic Classic Biphasic Pulmonary Blastoma Using Aggressive Tri-modality Treatment: Case Series and Review of the Literature
por: Lewis, Jennifer A, et al.
Publicado: (2018)

A transformer-based deep-learning approach for classifying brain metastases into primary organ sites using clinical whole-brain MRI images
por: Lyu, Qing, et al.
Publicado: (2022)

Dominant-negative SMARCA4 missense mutations alter the accessibility landscape of tissue-unrestricted enhancers
por: Hodges, H. Courtney, et al.
Publicado: (2017)

Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
por: Alistar, Angela, et al.
Publicado: (2014)

Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review
por: Duan, Huanli, et al.
Publicado: (2021)

The SMARCA4(R1157W) mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer
por: Zeng, Xiangwei, et al.
Publicado: (2023)

Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment
por: Song, Qianqian, et al.
Publicado: (2023)

Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
por: Zhang, Ali, et al.
Publicado: (2022)

Multi-Omics Analysis of Brain Metastasis Outcomes Following Craniotomy
por: Su, Jing, et al.
Publicado: (2021)

A two-faced selectivity solution to target SMARCA2 for cancer therapy
por: Harling, John D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lumg2dnmlkf681t75odo62uo0r